PLASMA LEVELS OF HEPARANASE AS A MARKER OF TUMOR PROGRESSION AND AGGRESSIVENESS IN PATIENTS WITH COLORECTAL AND BREAST CANCER

被引：0
|
作者：
Kuten, J. [1 ]
Haim, N. [2 ]
Epelbaum, R. [1 ]
Fried, G. [1 ]
Ben Itzhak, O. [3 ]
Danus, S. [1 ]
Shaft, I. [3 ]
Vlodavsky, I. [3 ]
机构：
[1] Rambam Med Ctr, Haifa, Israel
[2] Rambam Hlth Care Campus, Oncol, Haifa, Israel
[3] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [21] Plasma Exosome miR-203a-3p is a Potential Liquid Biopsy Marker for Assessing Tumor Progression in Breast Cancer Patients
    Yang, Xin
    Fan, Lei
    Huang, Jicheng
    Li, Yongjun
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 631 - 643
  • [22] PLASMA LEVELS OF PIRNAS AS BIOMARKERS FOR PROGNOSIS AND PREDICTING TUMOR RECURRENCE IN COLORECTAL CANCER PATIENTS
    Ozawa, Tsuyoshi
    Toiyama, Yuji
    Takahashi, Naoki
    Nagasaka, Takeshi
    Fujiwara, Toshiyoshi
    Yamada, Yasuhide
    Kusunoki, Masato
    Watanabe, Toshiaki
    Goel, Ajay
    GASTROENTEROLOGY, 2017, 152 (05) : S152 - S152
  • [23] Estrogen receptor beta as a marker of tumor progression and prognosis in colorectal cancer.
    Stevanato Filho, Paulo Roberto
    Aguiar, Samuel
    Begnami, Maria D.
    Ferreira, Fabio Oliveira
    Nakagawa, Wilson Toshihiko
    Sobreira Batista, Ranyell Spencer
    Melio, Celso Lopes
    Lopes, Ademar
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] COX-2 induction by heparanase in the progression of breast cancer
    Imada, T
    Matsuoka, J
    Nobuhisa, T
    Okawa, T
    Murata, T
    Tabuchi, Y
    Shirakawa, Y
    Ohara, N
    Gunduz, M
    Nagatsuka, H
    Umeoka, T
    Yamamoto, Y
    Nakajima, M
    Tanaka, N
    Naomoto, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (02) : 221 - 228
  • [25] Heparanase Accelerates Obesity-Associated Breast Cancer Progression
    Hermano, Esther
    Goldberg, Rachel
    Rubinstein, Ariel M.
    Sonnenblick, Amir
    Maly, Bella
    Nahmias, Daniela
    Li, Jin-Ping
    Bakker, Marinka A. H.
    van der Vlag, Johan
    Vlodavsky, Israel
    Peretz, Tamar
    Elkin, Michael
    CANCER RESEARCH, 2019, 79 (20) : 5342 - 5354
  • [26] DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer
    Nakopoulou, L
    Lazaris, A
    Kavantzas, N
    Alexandrou, P
    Athanassiadou, P
    Keramopoulos, A
    Davaris, P
    PATHOBIOLOGY, 2000, 68 (03) : 137 - 143
  • [27] Application of tumor marker antigens on immunotherapy of patients with colorectal cancer
    Lisovenko, SG
    Potebnya, GP
    Kolesnik, EA
    Kikot, VV
    EXPERIMENTAL ONCOLOGY, 2002, 24 (04) : 258 - 264
  • [28] Heparanase (HPSE) Associates with the Tumor Immune Microenvironment in Colorectal Cancer
    Liu, Mengling
    Liu, Qing
    Yuan, Yitao
    Li, Suyao
    Dong, Yu
    Liang, Li
    Zou, Zhiguo
    Liu, Tianshu
    PROCESSES, 2021, 9 (09)
  • [29] L1 Expression as a Marker for Poor Prognosis, Tumor Progression, and Short Survival in Patients with Colorectal Cancer
    Yoon-Jung Boo
    Joong-Min Park
    Jin Kim
    Yang-Seok Chae
    Byung-Wook Min
    Jun-Won Um
    Hong-Young Moon
    Annals of Surgical Oncology, 2007, 14 : 1703 - 1711
  • [30] L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer
    Boo, Yoon-Jung
    Park, Joong-Min
    Kim, Jin
    Chae, Yang-Seok
    Min, Byung-Wook
    Um, Jun-Won
    Moon, Hong-Young
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (05) : 1703 - 1711
12345